CLASS II Drug recall · Reported 5 Mar 2025 · FDA Enforcement Report
Avastin 1.25 mg/ in Syringe recalled by Turbare Manufacturing
Turbare Manufacturing is recalling Avastin 1.25 mg/ in Syringe, For Intravitreal Injection Only, Office Use Only - Not for, distributed nationwide in the US. The recall was initiated on 18 Feb 2025 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0248-2025
- FDA event ID
- 96306
- Recalling firm
- Turbare Manufacturing, Conway, AR
- Classification
- Class II
- Status
- Completed
- Recall initiated
- 18 Feb 2025
- FDA classified
- 21 Feb 2025
- Reported
- 5 Mar 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 18 Feb 2025 | Recall initiated by company | |
| 21 Feb 2025 | Classified by FDA | +3 days |
| 5 Mar 2025 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility: due to a quality control process deviation
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
Where it was distributed
Nationwide in the USA
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility: due to a quality control process deviation
Which lots are affected?
Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other Avastin recalls
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Avastin 630 MG / 0.9% Nacl Ivpb recalled by Infusion Options | Infusion Options | Sterility | NY |
| Drug | CLASS II | Avastin, 25MG/ML Syringe, [a) recalled by RXQ Compounding | RXQ Compounding | Sterility | Nationwide |
| Drug | CLASS II | Avastin 1.25 mg/ prefilled syringe recalled by Ranier's Compounding | Ranier's Compounding Laboratory | Sterility | PA |
| Drug | CLASS II | Avastin, solution, 1.25 mg/, Injectable, Syringe recalled | Montana Compounding Pharmacy | Sterility | MT, ND |
| Drug | CLASS II | Avastin, 1.25mg/, injectable plastic syringe, RX recalled | Oregon Compounding Centers | Sterility | OR, WA |